
This study aimed to validate Vergouwe's prediction model using the Swedish and Norwegian Testicular Cancer Group (SWENOTECA) RETROP database and to define its clinical utility. Overall, 284 patients were included in the analysis, of whom 130 (46%) had benign histology after PC‐RPLND. Discrimination analysis showed good reproducibility, with an area under the receiver‐operating characteristic curve (AUC) of 0.82 compared to Vergouwe's prediction model. The model was externally validated with good reproducibility. The model may identify patients with a high chance of benign histopathology in a clinical setting, thereby sparing patients from surgery.
Like
Save
Share